1. Cannabidiol and substance use disorder: Dream or reality. (1st April 2022) Authors: Karimi-Haghighi, Saeideh; Razavi, Yasaman; Iezzi, Daniela; Scheyer, Andrew F.; Manzoni, Olivier; Haghparast, Abbas Journal: Neuropharmacology Issue: Volume 207(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cannabidiol microinjection into the nucleus accumbens attenuated nociceptive behaviors in an animal model of tonic pain. (25th September 2021) Authors: Razavi, Yasaman; Rashvand, Mina; Sharifi, Asrin; Haghparast, Amir; Keyhanfar, Fariborz; Haghparast, Abbas Journal: Neuroscience letters Issue: Volume 762(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Neuroprotective effect of chronic administration of cannabidiol during the abstinence period on methamphetamine-induced impairment of recognition memory in the rats. Issue 4 (June 2020) Authors: Razavi, Yasaman; Shabani, Ronak; Mehdizadeh, Mehdi; Haghparast, Abbas Journal: Behavioural pharmacology Issue: Volume 31:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. NMDA receptor dependent changes in c-fos and p-CREB signaling following extinction and reinstatement of morphine place preference. (1st January 2018) Authors: Siahposht-Khachaki, Ali; Ezzatpanah, Somayeh; Razavi, Yasaman; Haghparast, Abbas Journal: Neuroscience letters Issue: Volume 662(2018) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗